Detalhe da pesquisa
1.
Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Cancer
; 127(13): 2204-2212, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33765337
2.
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
Lancet Oncol
; 19(3): 405-415, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439857
3.
Sleep disturbance in men receiving androgen deprivation therapy for prostate cancer: The role of hot flashes and nocturia.
Cancer
; 124(3): 499-506, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29072790
4.
Effect of androgen deprivation therapy on sexual function and bother in men with prostate cancer: A controlled comparison.
Psychooncology
; 27(1): 316-324, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28557112
5.
Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Cancer
; 123(23): 4566-4573, 2017 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28832978
6.
Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma.
J Vasc Interv Radiol
; 28(2): 254-259, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27955832
7.
Clinical role of additional adjuvant chemotherapy in patients with locally advanced urothelial carcinoma following neoadjuvant chemotherapy and cystectomy.
World J Urol
; 34(11): 1567-1573, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27072536
8.
Changes in physical functioning and muscle strength in men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Support Care Cancer
; 24(5): 2201-2207, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26563183
9.
Characteristics and predictors of fatigue among men receiving androgen deprivation therapy for prostate cancer: a controlled comparison.
Support Care Cancer
; 24(10): 4159-66, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27142516
10.
Course and Moderators of Hot Flash Interference during Androgen Deprivation Therapy for Prostate Cancer: A Matched Comparison.
J Urol
; 194(3): 690-5, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25791402
11.
Minimally invasive post-chemotherapy retroperitoneal lymph node dissection for nonseminoma.
Can J Urol
; 22(4): 7882-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26267026
12.
Axitinib with or without dose titration for first-line metastatic renal-cell carcinoma: a randomised double-blind phase 2 trial.
Lancet Oncol
; 14(12): 1233-42, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24140184
13.
Targeted therapy of kidney cancer: keeping the art around the algorithms.
Cancer Control
; 20(3): 222-32, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23811706
14.
Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer.
Cancer Control
; 20(1): 7-16, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23302902
15.
A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Clin Genitourin Cancer
; 20(1): 1-10, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34364796
16.
Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Cardiovasc Intervent Radiol
; 44(11): 1755-1762, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34312688
17.
A Single-arm, Multicenter, Phase 2 Study of Lenvatinib Plus Everolimus in Patients with Advanced Non-Clear Cell Renal Cell Carcinoma.
Eur Urol
; 80(2): 162-170, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33867192
18.
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial.
Eur J Cancer
; 145: 1-10, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412465
19.
Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma.
Cancer Control
; 17(4): 269-78, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20861814
20.
Angiogenic and Immune-Related Biomarkers and Outcomes Following Axitinib/Pembrolizumab Treatment in Patients with Advanced Renal Cell Carcinoma.
Clin Cancer Res
; 26(21): 5598-5608, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32816890